Research Article
Efficacy of Transarterial Chemoembolisation with or without Antiviral Therapy for Patients with Hepatocellular Carcinoma after Radical Hepatectomy
Table 2
Postoperative demographic characteristics of patients in the three groups.
| Postoperative patient demographic | Control group | TACE group | Combined group | value |
| Edmondson grade | I | 1 (2.5%) | 1 (2.5%) | 1 (2.5%) | 0.677 | II | 16 (40.0%) | 18 (45.0%) | 20 (50.0%) | III | 15 (37.5%) | 14 (35%) | 13 (32.5%) | IV | 8 (20.0%) | 7 (17.5%) | 6 (15.0%) |
| AJCC tumour stage | I | 36 (90.0%) | 34 (85.0%) | 37 (92.5%) | 0.549 | II | 4 (10.0%) | 6 (15.0%) | 3 (7.5%) |
| Tumour number | 1 | 36 (90.0%) | 35 (87.5%) | 37 (92.5%) | 0.759 | 2 | 4 (10.0%) | 5 (12.5%) | 3 (7.5%) |
| Maximum tumour size (cm) | | 4.31 ± 0.48 | 4.01 ± 0.67 | 3.84 ± 0.68 | 0.004 |
| Fibrous capsule formation | Yes | 4 (10.0%) | 5 (12.5%) | 6 (15.0%) | 0.797 | No | 36 (90.0%) | 35 (87.5%) | 34 (85.0%) |
| Tumour invasion in capsule | Yes | 0 (0.0%) | 4 (10.0%) | 3 (7.5%) | 0.141 | No | 40 (100.0%) | 36 (90.0%) | 37 (92.5%) |
| Microvascular invasion | Yes | 6 (15.0%) | 8 (20.0%) | 4 (10.0%) | 0.459 | No | 34 (85.0%) | 32 (80.0%) | 36 (90.0%) |
| Portal vein invasion | Yes | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 | No | 40 (100.0%) | 40 (100.0%) | 40 (100.0%) |
| Serosa invasion | Yes | 0 (0.0%) | 1 (2.5%) | 0 (0.0%) | 0.368 | No | 40 (100.0%) | 39 (97.5%) | 40 (100.0%) |
| Satellite nodule | Yes | 4 (10.0%) | 7 (17.5%) | 4 (10.0%) | 0.507 | No | 36 (90.0%) | 33 (82.5%) | 36 (90.0%) |
| Surgical margin invasion | Yes | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 | No | 40 (100.0%) | 40 (100.0%) | 40 (100.0%) |
| Safety margin (cm) | | 2.60 ± 0.81 | 2.85 ± 1.05 | 2.68 ± 1.02 | 0.497 |
| p53 | Positive | 16 (40.0%) | 19 (47.5%) | 20 (50.0%) | 0.649 | Negative | 24 (60.0%) | 21 (52.5%) | 20 (50.0%) |
|
|